CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK), a Phase 3 clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a ...
There's a whole world under the surface and only Ron has any idea about it. And sometimes the two worlds collide, and sometimes they don't. Ron holds them at arm's length from each other. Watch every ...
NEW YORK, April 4, 2022 /PRNewswire/ -- One Rock Capital Partners, LLC ("One Rock"), a value-oriented, operationally focused private equity firm, is pleased to announce the addition of Andrea ("AJ") ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results